Effect of polymorphisms of MTHFR in controlled ovarian stimulation: a systematic review and meta-analysis
- 25 May 2021
- journal article
- review article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 38 (9) , 2237-2249
Abstract
Objective Although several studies have reported a potential impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on controlled ovarian stimulation (COS), the results remain controversial. The aim of the systematic review and meta-analysis was to evaluate the effect of MTHFR polymorphism on COS outcomes. Methods PubMed, Web of Science, Embase, and Cochrane Central Register of Controlled Trials databases were searched up to December 2, 2020. COS clinical outcomes based on gene polymorphisms were included. Two reviewers independently extracted the data. The primary outcome was the number of oocytes retrieved. The secondary outcomes were the number of metaphase II (MII) oocytes, stimulation duration, basal follicle-stimulating hormone (FSH) level, FSH dosage, positive pregnancy test, ongoing pregnancy rate, clinical pregnancy rate, miscarriage rate, and live birth rate. Meta-analysis was performed using a fixed-effect model or random-effect model with Review Man 5.3.5. Mean difference (MD) with 95% confidence intervals (95%CIs) was calculated for continuous outcomes. The quality assessment of included studies was evaluated by using the Newcastle-Ottawa Scale. Results Eleven studies were included in the systematic review, and seven studies with 2015 participants were included in the meta-analysis. Basal FSH level was significantly lower in CC homozygotes than TT homozygotes (four studies, 867 participants, MD − 0.54, 95%CI − 0.85 to − 0.23, P = 0.0006; I2 = 0%) of MTHFR (rs1801133). FSH dose was significantly fewer in CC homozygotes compared with CT heterogeneous (three studies, 949 participants, MD − 75.78, 95%CI − 135.23 to − 16.33, P = 0.01; I2 = 32%) or CT/TT model (three studies, 1097 participants, MD − 80.18, 95%CI − 135.54 to − 24.81, P = 0.005; I2 = 42%). Differences in the oocytes retrieved and stimulation duration were insignificant. Gene variants on MTHFR (rs1801133) and MTHFR (rs1801131) were reported in ongoing pregnancy rate, clinical pregnancy rate, and live birth rate. Conclusion Studies to date indicate that polymorphisms of MTHFR could influence basal FSH level and FSH dose. The results could be useful to promote clinical practice on COS protocols. Further studies are needed to evaluate the clinical relevance of the multigene combination on COS.Keywords
This publication has 46 references indexed in Scilit:
- Determination and interpretation of MTHFR gene mutations in gynecology and internal medicinePolish Archives of Internal Medicine, 2019
- Sequence variants in FSHR and CYP19A1 genes and the ovarian response to controlled ovarian stimulationFertility and Sterility, 2019
- Pharmacogenomics in IVF: A New Era in the Concept of Personalized MedicineReproductive Sciences, 2019
- The relationship between FSH receptor polymorphism status and IVF cycle outcome: a retrospective observational studyReproductive BioMedicine Online, 2019
- Combined assessment of polymorphisms in theLHCGRandFSHRgenes predict chance of pregnancy afterin vitrofertilizationHuman Reproduction, 2016
- Comparison of different stimulation protocols used in in vitro fertilization: a review2015
- A single nucleotide polymorphism of bone morphogenic protein-15 is not associated with ovarian reserve or response to ovarian stimulationHuman Reproduction, 2014
- Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocolsReproductive Biology and Endocrinology, 2012
- Preconception Folic Acid Use Modulates Estradiol and Follicular Responses to Ovarian StimulationThe Journal of Clinical Endocrinology & Metabolism, 2011
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994